These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7965636)

  • 21. The effects of long term zidovudine therapy and Pneumocystis carinii prophylaxis on HIV disease. A review of the literature.
    Hoover DR
    Drugs; 1995 Jan; 49(1):20-36. PubMed ID: 7705214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Chaisson RE; Moore RD; Richman DD; Keruly J; Creagh T
    Am Rev Respir Dis; 1992 Aug; 146(2):285-9. PubMed ID: 1362634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival and medical intervention in southern Brazilian AIDS patients.
    Santos B; Beck EJ; Peixoto MF
    Int J STD AIDS; 1994; 5(4):279-83. PubMed ID: 7948159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of morbidity and mortality in AIDS patients on Pneumocystis carinii prophylaxis who died during hospital admission: a report of 50 diseased patients.
    Hentzen BT; Schreij G
    Neth J Med; 1996 Sep; 49(3):101-5. PubMed ID: 8854672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection.
    Selwyn PA; Alcabes P; Hartel D; Buono D; Schoenbaum EE; Klein RS; Davenny K; Friedland GH
    N Engl J Med; 1992 Dec; 327(24):1697-703. PubMed ID: 1359411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
    Hoover DR; Saah AJ; Bacellar H; Phair J; Detels R; Anderson R; Kaslow RA
    N Engl J Med; 1993 Dec; 329(26):1922-6. PubMed ID: 7902536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AIDS specialist versus generalist ambulatory care for advanced HIV infection and impact on hospital use.
    Turner BJ; McKee L; Fanning T; Markson LE
    Med Care; 1994 Sep; 32(9):902-16. PubMed ID: 8090043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival and mortality patterns of an acquired immunodeficiency syndrome (AIDS) cohort in New York State.
    Chang HG; Morse DL; Noonan C; Coles B; Mikl J; Rosen A; Putnam D; Smith PF
    Am J Epidemiol; 1993 Sep; 138(5):341-9. PubMed ID: 8356973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of generalists' slow adoption of zidovudine in clinical practice.
    Markson LE; Cosler LE; Turner BJ
    Arch Intern Med; 1994 Jul; 154(13):1497-504. PubMed ID: 8018005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival for women and men with AIDS.
    Lemp GF; Hirozawa AM; Cohen JB; Derish PA; McKinney KC; Hernandez SR
    J Infect Dis; 1992 Jul; 166(1):74-9. PubMed ID: 1607710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved short-term survival of AIDS patients initially diagnosed with Pneumocystis carinii pneumonia, 1984 through 1987.
    Harris JE
    JAMA; 1990 Jan; 263(3):397-401. PubMed ID: 2294306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group.
    McNaghten AD; Hanson DL; Jones JL; Dworkin MS; Ward JW
    AIDS; 1999 Sep; 13(13):1687-95. PubMed ID: 10509570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival of patients receiving zidovudine before or after AIDS diagnosis: results of a German multicenter study. German AIDS Study Group.
    Clin Investig; 1994 Jan; 72(2):111-6. PubMed ID: 8186655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of care for and outcomes of Pneumocystis carinii pneumonia among persons with transfusion-acquired AIDS.
    Bennett CL; Horner RD; Aboulafia D; Weinstein RA
    Transfusion; 1995 Aug; 35(8):674-8. PubMed ID: 7631408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991.
    Hessol NA; Koblin BA; van Griensven GJ; Bacchetti P; Liu JY; Stevens CE; Coutinho RA; Buchbinder SP; Katz MH
    Am J Epidemiol; 1994 Jun; 139(11):1077-87. PubMed ID: 8192140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users.
    Turner BJ; Laine C; Cosler L; Hauck WW
    J Gen Intern Med; 2003 Apr; 18(4):248-57. PubMed ID: 12709091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group.
    Lundgren JD; Phillips AN; Pedersen C; Clumeck N; Gatell JM; Johnson AM; Ledergerber B; Vella S; Nielsen JO
    JAMA; 1994 Apr; 271(14):1088-92. PubMed ID: 8151850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting survival in AIDS: refining the model.
    Hutchinson SJ; Brettle RP; Gore SM
    QJM; 1997 Nov; 90(11):685-92. PubMed ID: 9474349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of zidovudine therapy in minority and other subpopulations with early HIV infection.
    Lagakos S; Fischl MA; Stein DS; Lim L; Volberding P
    JAMA; 1991 Nov; 266(19):2709-12. PubMed ID: 1942422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors influencing survival after AIDS: report from the Multicenter AIDS Cohort Study (MACS).
    Saah AJ; Hoover DR; He Y; Kingsley LA; Phair JP
    J Acquir Immune Defic Syndr (1988); 1994 Mar; 7(3):287-95. PubMed ID: 8106968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.